Related Experiment Video
Updated: Aug 16, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Pneumonia in chronic obstructive lung disease
1Department of Medicine, University of Texas Health Center, Tyler.
Abstract:
Despite the apparent common occurrence of pneumonia in patients with chronic obstructive pulmonary disease (COPD), there are little firm data on incidence, etiology, diagnostic procedures, and therapy in these patients. It appears that traditional respiratory pathogens such as the pneumococcus are declining in importance while "new" pathogens such as Pseudomonas sp., Moraxella catarrhalis, and Legionella sp. are becoming more important. The diagnosis of a specific etiologic agent is difficult in COPD and can be aided by obtaining specimens bronchoscopically. Directed therapy is optimal; however, empiric therapy is frequently unavoidable.
Insights
Pneumonia in chronic obstructive pulmonary disease (COPD) is common but poorly understood. Pathogen importance is shifting, and diagnosis and treatment in COPD patients present unique challenges.
Area of Science:
- Pulmonology
- Infectious Diseases
- Critical Care Medicine
Background:
- Pneumonia is a frequent complication in patients with chronic obstructive pulmonary disease (COPD).
- Limited data exist regarding the incidence, causes, diagnosis, and treatment of pneumonia specifically in COPD patients.
- Traditional respiratory pathogens may be decreasing in prevalence, with an increase in "atypical" pathogens.
Purpose of the Study:
- To review the current understanding of pneumonia in COPD patients.
- To highlight challenges in diagnosis and treatment.
- To discuss the evolving landscape of causative pathogens.
Main Methods:
- Literature review of existing studies on pneumonia in COPD.
- Analysis of trends in pathogen prevalence.
- Discussion of diagnostic modalities and therapeutic strategies.
Main Results:
- Traditional pathogens like Streptococcus pneumoniae may be declining in COPD pneumonia.
- Emerging pathogens such as Pseudomonas sp., Moraxella catarrhalis, and Legionella sp. appear to be increasing.
- Diagnosing specific etiologic agents in COPD pneumonia is challenging, often requiring bronchoscopic methods.
- While directed therapy is ideal, empiric treatment is frequently necessary.
Conclusions:
- Pneumonia in COPD requires specific consideration due to changing pathogens and diagnostic difficulties.
- Bronchoscopic techniques can aid in identifying causative agents.
- Effective management often involves a combination of empiric and targeted therapeutic approaches.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pneumonia I: Introduction